Pfizer Inc. (NEO:PFE)

Market Cap	183.82B
Revenue (ttm)	89.25B
Net Income (ttm)	11.26B
Shares Out	n/a
EPS (ttm)	1.98
PE Ratio	16.32
Forward PE	8.05
Dividend	n/a
Ex-Dividend Date	n/a

Volume	30,782
Average Volume	128,329
Open	10.57
Previous Close	10.60
Day's Range	10.35 - 10.57
52-Week Range	9.68 - 14.73
Beta	0.50
RSI	44.69
Earnings Date	Apr 29, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Cboe Canada
• Ticker Symbol: PFE

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD